An external pilot cluster randomised controlled trial of a theory-based intervention to improve appropriate polypharmacy in older people in primary care (PolyPrime): study protocol

Audrey Rankin, Cathal A Cadogan, Heather E Barry, Evie Gardner, Ashley Agus, Gerard J Molloy, Ashleigh Gorman, Cristín Ryan, Claire Leathem, Marina Maxwell, Gerard J Gormley, Alan Ferrett, Pat McCarthy, Tom Fahey, Carmel M Hughes, PolyPrime team, Audrey Rankin, Cathal A Cadogan, Heather E Barry, Evie Gardner, Ashley Agus, Gerard J Molloy, Ashleigh Gorman, Cristín Ryan, Claire Leathem, Marina Maxwell, Gerard J Gormley, Alan Ferrett, Pat McCarthy, Tom Fahey, Carmel M Hughes, PolyPrime team

Abstract

Background: The use of multiple medications (polypharmacy) is a concern in older people (≥65 years) and is associated with negative health outcomes. For older populations with multimorbidity, polypharmacy is the reality and the key challenge is ensuring appropriate polypharmacy (as opposed to inappropriate polypharmacy). This external pilot cluster randomised controlled trial (cRCT) aims to further test a theory-based intervention to improve appropriate polypharmacy in older people in primary care in two jurisdictions, Northern Ireland (NI) and the Republic of Ireland (ROI).

Methods: Twelve GP practices across NI (n=6) and the six counties in the ROI that border NI will be randomised to either the intervention or usual care group. Members of the research team have developed an intervention to improve appropriate polypharmacy in older people in primary care using the Theoretical Domains Framework of behaviour change. The intervention consists of two components: (1) an online video which demonstrates how a GP may prescribe appropriate polypharmacy during a consultation with an older patient and (2) a patient recall process, whereby patients are invited to scheduled medication review consultations with GPs. Ten older patients receiving polypharmacy (≥4 medications) will be recruited per GP practice (n=120). GP practices allocated to the intervention arm will be asked to watch the online video and schedule medication reviews with patients on two occasions; an initial and a 6-month follow-up appointment. GP practices allocated to the control arm will continue to provide usual care to patients. The study will assess the feasibility of recruitment, retention and study procedures including collecting data on medication appropriateness (from GP records), quality of life and health service use (i.e. hospitalisations). An embedded process evaluation will assess intervention fidelity (i.e. was the intervention delivered as intended), acceptability of the intervention and potential mechanisms of action.

Discussion: This pilot cRCT will provide evidence of the feasibility of a range of study parameters such as recruitment and retention, data collection procedures and the acceptability of the intervention. Pre-specified progression criteria will also be used to determine whether or not to proceed to a definitive cRCT.

Trial registration: ISRCTN, ISRCTN41009897 . Registered 19 November 2019. ClinicalTrials.gov, NCT04181879 . Registered 02 December 2019.

Keywords: Behaviour change; Complex intervention; General practice; Older people; Pilot study; Polypharmacy; Prescribing; Primary care; Process evaluation.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Overview of the PolyPrime study. *The follow-up time points for the control arm will be based on the average length of time from the completion of baseline data collection to 6 and 9 months post initial medication review in the intervention arm

References

    1. Office for National Statistics. Overview of the UK population: 2017. . Accessed 17 Feb 2020.
    1. Avorn J. Medication use in older patient, Better Policy could encourage better practice. JAMA. 2010;304(14):1606–1607. doi: 10.1001/jama.2010.1495.
    1. Cadogan CA, Ryan C, Hughes CM. Appropriate polypharmacy and medicine safety: when many is not too many. Drug Saf. 2016;39(2):109–116. doi: 10.1007/s40264-015-0378-5.
    1. Cadogan CA, Ryan C, Francis JJ, Gormley GJ, Passmore P, Kerse N, Hughes CM. Development of an intervention to improve appropriate polypharmacy in older people in primary care using a theory-based method. BMC Health Serv Res. 2016;16(1):661. doi: 10.1186/s12913-016-1907-3.
    1. The King’s Fund. Polypharmacy and medicines optimisation: making it safe and sound. 2013. . Accessed 17 Feb 2020.
    1. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655. doi: 10.1136/bmj.a1655.
    1. Medical Research Council. Developing and evaluating complex interventions: new guidance. 2008. . Accessed 17 Feb 2020.
    1. Cadogan CA, Ryan C, Hughes C. Making the case for change: what researchers need to consider when designing behavior change interventions aimed at improving medication dispensing. Res Social Adm Pharm. 2016;12(1):149–153. doi: 10.1016/j.sapharm.2015.04.002.
    1. Hughes CM, Cadogan CA, Ryan CA. Development of a pharmacy practice intervention: lessons from the literature. Int J Clin Pharm. 2016;38(3):601–606. doi: 10.1007/s11096-015-0180-6.
    1. Cadogan CA, Ryan C, Francis JJ, Gormley GJ, Passmore P, Kerse N, Hughes CM. Improving appropriate polypharmacy for older people in primary care: selecting components of an evidence-based intervention to target prescribing and dispensing. Implement Sci. 2015;10(1):161. doi: 10.1186/s13012-015-0349-3.
    1. Patton DE, Cadogan CA, Ryan C, Francis JJ, Gormley GJ, Passmore P, Kerse N, Hughes CM. Improving adherence to multiple medications in older people in primary care: selecting intervention components to address patient-reported barriers and facilitators. Health Expect. 2018;21(1):138–148. doi: 10.1111/hex.12595.
    1. Cane J, O’Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7(1):37. doi: 10.1186/1748-5908-7-37.
    1. Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Heal Care. 2005;14(1):26–33. doi: 10.1136/qshc.2004.011155.
    1. Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, Eccles MP, Cane J, Wood CE. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013;46(1):81–95. doi: 10.1007/s12160-013-9486-6.
    1. Cadogan CA, Ryan C, Gormley GJ, Francis JJ, Passmore P, Kerse N, et al. A feasibility study of a theory-based intervention to improve appropriate polypharmacy for older people in primary care. Pilot Feasibility Stud. 2017;4:23. doi: 10.1186/s40814-017-0166-3.
    1. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–218. doi: 10.1093/ageing/afu145.
    1. Bradley MC, Fahey T, Cahir C, Bennett K, O’Reilly D, Parsons C, Hughes CM. Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol. 2012;68(10):1425–1433. doi: 10.1007/s00228-012-1249-y.
    1. Bradley MC, Motterlini N, Padmanabhan S, Cahir C, Williams T, Fahey T, Hughes CM. Potentially inappropriate prescribing among older people in the United Kingdom. BMC Geriatr. 2014;14(1):72. doi: 10.1186/1471-2318-14-72.
    1. Cupples ME, Byrne MC, Smith SM, Leathem CS, Murphy AW. Secondary prevention of cardiovascular disease in different primary healthcare systems with and without pay-for-performance. Heart. 2008;94(12):1594–1600. doi: 10.1136/hrt.2008.145912.
    1. Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, Guthrie B, Lester H, Wilson P, Kinmonth AL. Designing and evaluating complex interventions to improve health care. BMJ. 2007;334(7591):455–459. doi: 10.1136/.
    1. Gorman A, Rankin A, Barry H, Cadogan C, Gormley G, Fahey T, et al. A qualitative study to refine a theory-based intervention to improve appropriate polypharmacy in older people in primary care. Int J Pharm Pract. 2020;28(Suppl 1):12.
    1. Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239. doi: 10.1136/bmj.i5239.
    1. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–207. doi: 10.7326/0003-4819-158-3-201302050-00583.
    1. Lewis T. Using the NO TEARS tool for medication review. BMJ. 2004;329(7463):434. doi: 10.1136/bmj.329.7463.434.
    1. National Institute for Health and Care Excellence. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes [NG5]. 2015. . Accessed 17 Feb 2020.
    1. Rankin A, Cadogan CA, Ryan C, Clyne B, Smith SM, Hughes CM. Core outcome set for trials aimed at improving the appropriateness of polypharmacy in older people in primary care. JAGS. 2018;66(6):1206–1212. doi: 10.1111/jgs.15245.
    1. Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011;20(10):1727–1736. doi: 10.1007/s11136-011-9903-x.
    1. Mohammed MA, Moles RJ, Hilmer SN, O’Donnel LK, Chen TF. Development and validation of an instrument for measuring the burden of medicine on functioning and well-being: the Medication-Related Burden Quality of Life (MRB-QoL) tool. BMJ Open. 2018;8(1):e018880. doi: 10.1136/bmjopen-2017-018880.
    1. Avery KNL, Williamson PR, Gamble C, O’Connell Francischetto E, Metcalfe C, Davidson P, et al. Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies. BMJ Open. 2017;7(2):e013537. doi: 10.1136/bmjopen-2016-013537.
    1. Borrelli B, Sepinwall D, Ernst D, Bellg AJ, Czajkowski S, Breger R, DeFrancesco C, Levesque C, Sharp DL, Ogedegbe G, Resnick B, Orwig D. A new tool to assess treatment fidelity and evaluation of treatment fidelity across 10 years of health behavior research. J Consult Clin Psychol. 2005;73(5):852–860. doi: 10.1037/0022-006X.73.5.852.
    1. Rankin A, Cadogan CA, Patterson SM, Kerse N, Cardwell CR, Bradley MC, Ryan C, Hughes C, Cochrane Effective Practice and Organisation of Care Group. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018; 10.1002/14651858.CD008165.pub4.
    1. French SD, Green SE, O’Connor DA, McKenzie JE, Francis JJ, Michie S, et al. Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the Theoretical Domains Framework. Implement Sci. 2012;7(1):38. doi: 10.1186/1748-5908-7-38.
    1. Thornton J. Covid-19: how coronavirus will change the face of general practice forever. BMJ. 2020;368:m1279. doi: 10.1136/bmj.m1279.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir